PSIX
Power Solutions International, Inc.
PSIX's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over PSIX overall, supported by stronger valuation and stronger fundamentals.
PSIX Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Strong | |
| Strong |
PSIX's cash flow and balance sheet are currently strong, and its profitability is stable, but its revenue is under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
PSIX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.1x | $9.56 | -76% |
| Fair | 10x | $31.91 | -19% |
| Forward | 11x | $39.42 | — |
| Current | 13x | $39.42 | — |
| Expensive | 17x | $52.04 | +32% |
Historical ranges are pointers, not guarantees.
PSIX's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its fair range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over PSIX in the historical PE scenario, which offers more potential upside but is not a forecast.
PSIX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for PSIX, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
PSIX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.54 | +16% |
| Q3 2026 | $3.04 | -42% |
| Q2 2026 | $2.94 | -39% |
| Q1 2026 | $4.43 | +25% |
| Q4 2025 | $4.94 | +64% |
| Q3 2025 | $5.26 | +122% |
| Q2 2025 | $4.81 | +145% |
| Q1 2025 | $3.53 | +172% |
| Q4 2024 | $3.01 | +162% |
PSIX's earnings per share have fallen from their peak: $3.04 over the past year, against $5.26 in late 2025.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT's earnings per share have climbed steadily: $5.35 over the past year, up 102% from the year before, and higher year over year every quarter since late 2021.
PSIX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $202.1M | -0.9% |
| Q2 2026 | $152.5M | -21% |
| Q1 2026 | $128.6M | -5.1% |
| Q4 2025 | $191.2M | +33% |
| Q3 2025 | $203.8M | +62% |
| Q2 2025 | $191.9M | +74% |
| Q1 2025 | $135.4M | +42% |
| Q4 2024 | $144.3M | +38% |
PSIX's revenue has held roughly level: $202M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +6.3 points |
| Q2 2026 | 16% | -1.3 points |
| Q1 2026 | 8.9% | -9.3 points |
| Q4 2025 | 13% | -4.8 points |
| Q3 2025 | 14% | -2.3 points |
| Q2 2025 | 17% | -6 points |
| Q1 2025 | 18% | +7 points |
| Q4 2024 | 17% | +5.7 points |
PSIX's operating margin was 20% last quarter, up 6.3 points from the same quarter a year ago, near the top of its range since 2019.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT's revenue has grown year over year every quarter since late 2020: $4.3B last quarter, up 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over PSIX on profitability, with a higher operating margin.
PSIX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $38.3M | +2119% |
| Q2 2026 | $55.7M | +281% |
| Q1 2026 | $17.2M | +219% |
| Q4 2025 | -$7.6M | -125% |
| Q3 2025 | $1.7M | -86% |
| Q2 2025 | $14.6M | +1679% |
| Q1 2025 | $5.4M | -63% |
| Q4 2024 | $30M | +398% |
PSIX generated $104M in free cash flow over the past year, up 100% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.
PSIX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +3K shares |
| 1 year | +0.1% | +14K shares |
| 3 years | +0.4% | +101K shares |
| 5 years | +0.7% | +155K shares |
| Available history | +7.2% | +1.5M shares |
PSIX has the edge over VRT on shareholder dilution, with a more favorable share count trend.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
PSIX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | 0.4x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.8x | Very low |
PSIX has the edge over VRT on leverage, with a lower net debt burden relative to earnings.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
PSIX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 49.7 | Neutral |
PSIX's weekly RSI is 44 (neutral) and its Stochastic is 50 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
PSIX PE vs Industrials Sector
| Metric | PSIX | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 24x | 46% below |
| PE % | 66 | 58 | 8 pts above |
PSIX has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
PSIX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.7 | 12% below |
| 20 week MA | $40.0 | 1.4% below |
| 50 week MA | $54.1 | 27% below |
| 100 week MA | $55.3 | 29% below |
| 200 week MA | $31.2 | 27% above |
PSIX has fallen below most of its moving averages, though it's still 27% above its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has the edge over PSIX on trend strength, trading above more of its moving averages.
PSIX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.25 | $3.26 | -23% |
| 2021 | $3.26 | $2.95 | -9.5% |
| 2022 | $2.95 | $2.92 | -1% |
| 2023 | $2.92 | $2.05 | -30% |
| 2024 | $2.05 | $27.1 | +1220% |
| 2025 | $27.1 | $65.5 | +142% |
| 2026 YTD | $65.5 | $39.4 | -40% |
PSIX has finished lower in four of the last six years. It's down 40% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over PSIX on returns for 2026, with the stronger performance.